292 related articles for article (PubMed ID: 16452178)
21. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
Ganesh S; Gonzalez Edick M; Idamakanti N; Abramova M; Vanroey M; Robinson M; Yun CO; Jooss K
Cancer Res; 2007 May; 67(9):4399-407. PubMed ID: 17483354
[TBL] [Abstract][Full Text] [Related]
22. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
23. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
24. Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model.
Tsai V; Johnson DE; Rahman A; Wen SF; LaFace D; Philopena J; Nery J; Zepeda M; Maneval DC; Demers GW; Ralston R
Clin Cancer Res; 2004 Nov; 10(21):7199-206. PubMed ID: 15534093
[TBL] [Abstract][Full Text] [Related]
25. Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters.
Bortolanza S; Alzuguren P; Buñuales M; Qian C; Prieto J; Hernandez-Alcoceba R
Hum Gene Ther; 2007 Aug; 18(8):681-90. PubMed ID: 17658991
[TBL] [Abstract][Full Text] [Related]
26. Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.
Han ZQ; Assenberg M; Liu BL; Wang YB; Simpson G; Thomas S; Coffin RS
J Gene Med; 2007 Feb; 9(2):99-106. PubMed ID: 17256802
[TBL] [Abstract][Full Text] [Related]
27. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models.
Wang Y; Hallden G; Hill R; Anand A; Liu TC; Francis J; Brooks G; Lemoine N; Kirn D
Nat Biotechnol; 2003 Nov; 21(11):1328-35. PubMed ID: 14555956
[TBL] [Abstract][Full Text] [Related]
28. An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.
Lichtenstein DL; Spencer JF; Doronin K; Patra D; Meyer JM; Shashkova EV; Kuppuswamy M; Dhar D; Thomas MA; Tollefson AE; Zumstein LA; Wold WS; Toth K
Cancer Gene Ther; 2009 Aug; 16(8):644-54. PubMed ID: 19197324
[TBL] [Abstract][Full Text] [Related]
29. New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.
Spencer JF; Sagartz JE; Wold WS; Toth K
Cancer Gene Ther; 2009 Dec; 16(12):912-22. PubMed ID: 19478829
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide enhances antitumor efficacy of oncolytic adenovirus expressing uracil phosphoribosyltransferase (UPRT) in immunocompetent Syrian hamsters.
Hasegawa N; Abei M; Yokoyama KK; Fukuda K; Seo E; Kawashima R; Nakano Y; Yamada T; Nakade K; Hamada H; Obata Y; Hyodo I
Int J Cancer; 2013 Sep; 133(6):1479-88. PubMed ID: 23444104
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S
Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
33. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.
Kirn D
Oncogene; 2000 Dec; 19(56):6660-9. PubMed ID: 11426652
[TBL] [Abstract][Full Text] [Related]
34. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
[TBL] [Abstract][Full Text] [Related]
35. A replication-selective adenoviral vector for head and neck cancers.
Tanaka H; Shirakawa T; Zhang Z; Hamada K; Gotoh A; Nibu K
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):630-4. PubMed ID: 16027288
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.
LaRocca CJ; Han J; Gavrikova T; Armstrong L; Oliveira AR; Shanley R; Vickers SM; Yamamoto M; Davydova J
Surgery; 2015 May; 157(5):888-98. PubMed ID: 25731784
[TBL] [Abstract][Full Text] [Related]
37. Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling.
Le LP; Le HN; Dmitriev IP; Davydova JG; Gavrikova T; Yamamoto S; Curiel DT; Yamamoto M
J Natl Cancer Inst; 2006 Feb; 98(3):203-14. PubMed ID: 16449680
[TBL] [Abstract][Full Text] [Related]
38. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
Crosby CM; Nehete P; Sastry KJ; Barry MA
J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
[TBL] [Abstract][Full Text] [Related]
40. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
Hoffmann D; Wildner O
Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]